Tiotropium bromide + Olodaterol
Sponsors
Boehringer Ingelheim
Conditions
COPDPulmonary Disease, Chronic Obstructive
Unknown Phase
Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS
CompletedNCT04138758
Start: 2019-11-01End: 2019-11-04Updated: 2021-11-15
Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study
CompletedNCT04926233
Start: 2019-11-15End: 2020-04-14Updated: 2021-11-15